Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Rule 38.5 - Pfizer INC

4 Nov 2015 11:32

RNS Number : 5273E
Morgan Stanley Capital Services LLC
04 November 2015
Β 

Β 

Β FORM 38.5(a)

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 38.5(a)Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANELΒ ACT,Β 1997, TAKEOVER Β RULES,Β 2013

Β 

DEALINGS BY CONNECTEDΒ EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARYΒ STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

Β 

Β 

1. KEYΒ INFORMATION

Β Name of exempt market-maker

Morgan Stanley Capital Services LLC

Β Company dealt in

PFIZER INC

Β Class of relevant security to which the dealings being disclosed relate (Note 1)

US$0.05 COMMON STOCK

Β Date of dealing

03 NOVEMBER 2015

Β 

Β 

2. DEALINGSΒ (NoteΒ 2)

Β 

(a) PurchasesΒ andΒ sales

Β Total number of relevant secuities accquired

Β Highest price paid (Note 3)

Β Lowest price paid (Note 3)

Β Β 945,665

Β 35.0600 USD

Β 34.6600 USD

Β 

Β Total number of relevant secuities disposed

Β Highest price paid (Note 3)

Β Lowest price paid (Note 3)

Β Β 57,210

Β 35.0600 USD

Β 34.6800 USD

Β 

Β 

(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Β Product name, e.g. CFD

Β Nature of transaction

(Note 4)

Β Number of relevant securities

(Note 5)

Β Price per unit

Β CFD

Β LONG

Β 217

Β 34.8471 USD

Β CFD

Β LONG

Β 1,773

Β 34.8707 USD

Β CFD

Β LONG

Β 16,590

Β 34.8860 USD

Β CFD

Β LONG

Β 200

Β 34.8950 USD

Β CFD

Β LONG

Β 477

Β 34.8971 USD

Β CFD

Β LONG

Β 500

Β 34.9057 USD

Β CFD

Β LONG

Β 29

Β 34.9227 USD

Β CFD

Β LONG

Β 2

Β 34.9227 USD

Β CFD

Β LONG

Β 427

Β 34.9227 USD

Β CFD

Β LONG

Β 3

Β 34.9227 USD

Β CFD

Β LONG

Β 92

Β 34.9227 USD

Β CFD

Β LONG

Β 128

Β 34.9419 USD

Β CFD

Β LONG

Β 5

Β 34.9419 USD

Β CFD

Β LONG

Β 3

Β 34.9419 USD

Β CFD

Β LONG

Β 597

Β 34.9419 USD

Β CFD

Β LONG

Β 40

Β 34.9419 USD

Β CFD

Β LONG

Β 600

Β 34.9433 USD

Β CFD

Β LONG

Β 1,180

Β 34.9454 USD

Β CFD

Β LONG

Β 16

Β 34.9500 USD

Β CFD

Β LONG

Β 184

Β 34.9500 USD

Β CFD

Β LONG

Β 6,428

Β 34.9520 USD

Β CFD

Β LONG

Β 3,300

Β 34.9520 USD

Β CFD

Β LONG

Β 400

Β 34.9528 USD

Β CFD

Β LONG

Β 248

Β 34.9700 USD

Β CFD

Β LONG

Β 2,100

Β 34.9700 USD

Β CFD

Β LONG

Β 10,400

Β 34.9704 USD

Β CFD

Β SHORT

Β 1,200

Β 34.6800 USD

Β CFD

Β SHORT

Β 4

Β 34.6975 USD

Β CFD

Β SHORT

Β 4

Β 34.6975 USD

Β CFD

Β SHORT

Β 133

Β 34.7048 USD

Β CFD

Β SHORT

Β 12

Β 34.7048 USD

Β CFD

Β SHORT

Β 290

Β 34.7163 USD

Β CFD

Β SHORT

Β 10

Β 34.7163 USD

Β CFD

Β SHORT

Β 6

Β 34.7163 USD

Β CFD

Β SHORT

Β 93

Β 34.7163 USD

Β CFD

Β SHORT

Β 1,366

Β 34.7163 USD

Β CFD

Β SHORT

Β 277

Β 34.7256 USD

Β CFD

Β SHORT

Β 106

Β 34.7256 USD

Β CFD

Β SHORT

Β 8,700

Β 34.7308 USD

Β CFD

Β SHORT

Β 62,008

Β 34.7405 USD

Β CFD

Β SHORT

Β 3,284

Β 34.7500 USD

Β CFD

Β SHORT

Β 16

Β 34.7500 USD

Β CFD

Β SHORT

Β 1,400

Β 34.7626 USD

Β CFD

Β SHORT

Β 2,100

Β 34.7666 USD

Β CFD

Β SHORT

Β 10,472

Β 34.7746 USD

Β CFD

Β SHORT

Β 2,673

Β 34.7751 USD

Β CFD

Β SHORT

Β 264

Β 34.7874 USD

Β CFD

Β SHORT

Β 383

Β 34.7874 USD

Β CFD

Β SHORT

Β 835

Β 34.8057 USD

Β CFD

Β SHORT

Β 240

Β 34.8200 USD

Β CFD

Β SHORT

Β 10,089

Β 34.8243 USD

Β CFD

Β SHORT

Β 5,692

Β 34.8254 USD

Β CFD

Β SHORT

Β 62

Β 34.8271 USD

Β CFD

Β SHORT

Β 919

Β 34.8271 USD

Β CFD

Β SHORT

Β 5

Β 34.8271 USD

Β CFD

Β SHORT

Β 202

Β 34.8271 USD

Β CFD

Β SHORT

Β 7

Β 34.8271 USD

Β CFD

Β SHORT

Β 2,200

Β 34.8377 USD

Β CFD

Β SHORT

Β 1,151

Β 34.8417 USD

Β CFD

Β SHORT

Β 392

Β 34.8500 USD

Β CFD

Β SHORT

Β 23,200

Β 34.8610 USD

Β CFD

Β SHORT

Β 5,500

Β 34.8685 USD

Β CFD

Β SHORT

Β 8,850

Β 34.8959 USD

Β CFD

Β SHORT

Β 600,000

Β 34.9334 USD

Β CFD

Β SHORT

Β 151,461

Β 34.9371 USD

Β CFD

Β SHORT

Β 400

Β 34.9400 USD

Β CFD

Β SHORT

Β 200

Β 34.9400 USD

Β CFD

Β SHORT

Β 1,000

Β 34.9400 USD

Β CFD

Β SHORT

Β 6,280

Β 34.9457 USD

Β CFD

Β SHORT

Β 5

Β 34.9500 USD

Β CFD

Β SHORT

Β 14

Β 34.9500 USD

Β CFD

Β SHORT

Β 200

Β 34.9550 USD

Β CFD

Β SHORT

Β 1,400

Β 34.9700 USD

Β CFD

Β SHORT

Β 280

Β 34.9769 USD

Β CFD

Β SHORT

Β 4,116

Β 34.9769 USD

Β CFD

Β SHORT

Β 35

Β 34.9769 USD

Β CFD

Β SHORT

Β 20

Β 34.9769 USD

Β CFD

Β SHORT

Β 889

Β 34.9769 USD

Β 

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Β Product name, eg call option

Β Writing, selling, purchasing, varying etc

Β Number of securities to which the option relates (Note 5)

Β Exercise Price

Β Type, e.g American, European etc

Β Expiry Date

Β Option money paid/received per unit (Note 3)

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β 

(ii) Exercising

Β 

Β Product name, eg call option

Β Number of securities

Β Exercise price per unit (Note 3)

Β N/A

Β N/A

Β N/A

Β 

Β 

3. OTHER INFORMATION

Β 

Agreements, arrangements or understandings relating to options or derivatives

Β 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β Date of disclosure

Β 04 NOVEMBER 2015

Β Contact Name

Craig Horsley

Β Telephone Number

+44(141) 245 7736

Β Name of offeree/offeror with which connected

ALLERGAN PLC

Nature of connection (Note 6)

Advisory

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ISEBIBBTMBTMBLA
Date   Source Headline
17th Nov 20153:32 pmRNSForm 8.3 - Pfizer Inc Amendment
17th Nov 20153:32 pmRNSForm 8.3 - Pfizer Inc
17th Nov 20153:21 pmRNSForm 8.3 - Pfizer Inc
17th Nov 20153:16 pmRNSForm 8.3 - [PFIZER INC]
17th Nov 20153:14 pmRNSForm 8.3 - Allergan plc
17th Nov 20152:56 pmBUSForm 8.3 - Pfizer Inc.
17th Nov 20152:45 pmRNSForm 8.3 - ALLERGAN PLC
17th Nov 20152:36 pmRNSForm 8.3 - PFIZER INC
17th Nov 20152:27 pmRNSForm 8.3 - Pfizer Inc.
17th Nov 20152:26 pmRNSRule 38.5 - Replacement Pfizer INC
17th Nov 20152:24 pmRNSForm 8.3 - Pfizer Inc
17th Nov 20152:23 pmRNSForm 8.3 - Allergan plc
17th Nov 20152:07 pmRNSForm 8.3 - Allergan Plc
17th Nov 201512:10 pmRNSForm 38.5a
17th Nov 201512:09 pmRNSForm 38.5b
17th Nov 201512:07 pmRNSForm 38.5b
17th Nov 201512:03 pmRNSForm 8.1 - [Pfizer Inc]
17th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
17th Nov 201511:43 amRNSForm 38.5(b) - Pfizer Inc
17th Nov 201511:16 amRNSForm 38.5(a) - Pfizer Inc
17th Nov 201510:30 amRNSRule 38.5 - Pfizer INC
17th Nov 201510:29 amRNSRule 38.5 - Pfizer INC
17th Nov 201510:28 amRNSRule 38.5 - Pfizer INC
17th Nov 20157:00 amRNSForm 8.3 - Pfizer, Inc Replacement non material
16th Nov 20154:05 pmRNSForm 8.3 - Allergan PLC
16th Nov 20153:52 pmRNSForm 8.3 - PFIZER INC
16th Nov 20153:49 pmRNSForm 8.3 - PFIZER INC.
16th Nov 20153:34 pmRNSForm 8.3 - Pfizer Inc
16th Nov 20153:27 pmRNSForm 8.3 - Allergan plc
16th Nov 20153:25 pmRNSForm 8.3 - Allergan plc
16th Nov 20153:13 pmRNSForm 8.3 - Pfizer Inc
16th Nov 20153:12 pmRNSForm 8.3 - Pfizer Inc Amendment
16th Nov 20153:05 pmRNSForm 8.3 - [PFIZER INC]
16th Nov 20153:03 pmRNSForm 8.3 - Pfizer Inc
16th Nov 20153:02 pmBUSForm 8.3 - Pfizer Inc.
16th Nov 20152:47 pmRNSForm 8.3 - Pfizer, Inc.
16th Nov 20152:41 pmRNSForm 8.3 - Pfizer Inc
16th Nov 20152:28 pmRNSForm 8.3 - Allergan Plc
16th Nov 201512:03 pmRNSForm 38.5b
16th Nov 201512:03 pmRNSForm 8.1- [Pfizer]
16th Nov 201512:03 pmRNSForm 38.5a
16th Nov 201512:01 pmRNSForm 38.5b
16th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc
16th Nov 201511:50 amRNSForm 38.5b
16th Nov 201511:49 amRNSForm 38.5(b) - Pfizer Inc
16th Nov 201511:32 amRNSForm 8.1a - Pfizer Inc
16th Nov 201511:10 amRNSRule 38.5 - Pfizer INC
16th Nov 201511:09 amRNSRule 38.5 - Pfizer INC
16th Nov 201511:09 amRNSRule 38.5 - Pfizer INC
13th Nov 20155:16 pmRNSForm 38.5(b) - Pfizer Inc. - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.